- Report
- February 2024
- 200 Pages
Global
From €6683EUR$7,500USD£5,798GBP
- Report
- November 2023
- 30 Pages
Global
From €2896EUR$3,250USD£2,512GBP
- Report
- September 2022
- 288 Pages
Global
From €8465EUR$9,500USD£7,344GBP
- Report
- September 2022
- 160 Pages
Global
From €3520EUR$3,950USD£3,054GBP
- Report
- September 2022
- 144 Pages
Global
From €4233EUR$4,750USD£3,672GBP
- Report
- January 2022
- 60 Pages
Global
From €3520EUR$3,950USD£3,054GBP
- Report
- February 2025
- 85 Pages
India
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- October 2024
- 87 Pages
Spain
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- September 2024
- 82 Pages
Japan
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- August 2024
- 85 Pages
India
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- August 2024
- 82 Pages
Japan
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- June 2024
- 182 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- May 2024
- 184 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- May 2024
- 184 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- February 2024
- 184 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- February 2024
- 170 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- February 2024
- 172 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- November 2023
- 171 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- November 2023
- 90 Pages
France
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- November 2023
- 81 Pages
Germany
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more